Navigation Links
Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients
Date:1/8/2012

rights to some parts of its intellectual property portfolio for the development of other products to ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, including the antibody IMC-3C5 targeting VEGFR-3.
www.circadian.com.au

About Circadian's pipeline of treatments for cancerThe clinical and commercial success of Avastin®, an antibody that blocks the activity of VEGF-A, clinically validated anti-angiogenic drugs as an effective means of inhibiting solid tumour growth.  By blocking the interaction of VEGF- A with its receptors, primarily VEGFR-2, the multi-billion dollar cancer therapeutic slows tumour growth by inhibiting blood vessel recruitment into the tumour, effectively starving tumours of essential nutrients and oxygen required for growth. However after a short period of time tumors can begin to grow again in the presence of Avastin®. Avastin® is approved  by the US FDA in the following indications: metastatic colorectal cancer, non-squamous-cell lung cancer, glioblastoma, and metastatic renal cell carcinoma. In Europe it is approved for the additional indications of ovarian cancer and breast cancer.

The angiogenic receptor VEGFR-2 can also be stimulated by VEGF-C and hence an inhibitor such as VGX-100, a key therapeutic in Circadian's portfolio, can produce greater blockade of this receptor pathway when  used in combination with VEGF-A inhibitors.  As such, VGX-100 has the potential to block blood vessel growth in tumours which grow despite ongoing  Avastin® therapy and hence may completely shut down angiogenesis (the growth of blood vessels) mediated by VEGFR-2.

VEGF-C, along with the molecule VEGF-D, are also the only known proteins to bind and activate VEGFR-3 which drives lymphatic vessel and tumour-associated blood vessel growth.  Inhibitors of VEGF-C thus have therapeutic potential to inhibit not only primary tumou
'/>"/>

SOURCE Circadian Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Circadiance Launches Revolutionary New CPAP Tube
2. Circadian Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors
3. Circadian Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors
4. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
5. Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix
6. Coronado Biosciences Commences Public Trading on the OTC Bulletin Board
7. Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City
8. CryoLife Commences Tender Offer for All Outstanding Shares of Cardiogenesis Corporation
9. Unilife Commences Initial Production of Unifill Prefilled Syringe
10. Quest Diagnostics Commences Tender Offer for Acquisition of Celera
11. Milestone Scientific Inc. Commences Trading on the OTC Pink
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 3, 2015 Today, the world,s ... As markets become ever more transparent, the importance of ... recognised long ago. Its maxim of "innovation brings progress ... and digitisation. The company has long been ... of the art" technology and modern approach, while also ...
(Date:6/2/2015)... 2, 2015  Endo International plc (NASDAQ: ENDP ... that it has commenced an underwritten public offering of ... shares in the offering are to be sold by ... to the underwriters of the Offering an option, exercisable ... of the final prospectus supplement, to purchase an additional ...
(Date:6/2/2015)...  MGC Diagnostics Corporation (NASDAQ: MGCD ), ... results for the second quarter ended April 30, ... equipment, supplies and accessories revenues, compared to the ... During the quarter, competitive account conversions totaled 12 ... accounts, or $850,000 in revenue for the same ...
Breaking Medicine Technology:Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 2Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 3Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 12MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 13MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 14
... 2007 - Lux Biosciences,Inc., a privately held biotechnology ... today that the company's,next-generation calcineurin inhibitor, LX211, is ... Research in Vision and,Ophthalmology (ARVO) annual meeting, being ... an oral presentation being given on May 5 ...
... at 59th American Academy of Neurology Annual Meeting, ... /PRNewswire/ --,PTC Therapeutics, Inc. (PTC), a biopharmaceutical company ... targeting,post-transcriptional control processes, today announced positive,interim data from ... patients,with Duchenne muscular dystrophy (DMD) due to a ...
Cached Medicine Technology:Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 2Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 3Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 4PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 5
(Date:6/3/2015)... Veatch Consulting Services is excited to announce their achievement ... in April 2006, they have made it a priority ... and every year they have worked diligently in surpassing ... that they are off to a great start already ... year is the Customer Review site veatchconsultingreviews.weebly.com. At this ...
(Date:6/3/2015)... Israel (PRWEB) June 03, 2015 evigilo, ... multi-channel solutions, has showcased its new branding by launching ... , "The new brand identity: the logo depicting ... red, to green, the tagline – To Know. To ... new path evigilo is charting. A global, borderless approach ...
(Date:6/2/2015)... 02, 2015 The organic cotton market ... Report, an annual study conducted by Textile Exchange, an ... industry. The report, released today, encompasses extensive data about ... worldwide level and also takes the opportunity to celebrate ... , The last several years have been ...
(Date:6/2/2015)... Aidan Booth And Steve Clayton's ... yesterday, and has since received rave reviews from ... Tiffany Hendricks has weighed in with her opinion ... on her website HonestyFirstReviews.com. , "These days the ... looking to hone their business skills has gotten ...
(Date:6/2/2015)... June 02, 2015 April 8th, 2015, ... venue into Durkin Entertainment’s “RockNRolla Movie Awards” EcoLuxe Lounge, ... that gathered some of the world’s top providers of ... event was organized by Debbie Durkin, Los Angeles’ leading ... the EcoLuxe Lounge is a premier red carpet event ...
Breaking Medicine News(10 mins):Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2Health News:Choices Recovery South Bend Discusses Addiction With Rising Hollywood Star Ben Stillwell 2
... usually reserved,for lighthearted fun and entertainment, the hallways ... kind of gathering Monday, as child-health,and education experts ... trends in Jordan. Her Majesty Queen Rania Al ... Jordan there, bringing some,welcomed news about the Kingdom,s ...
... estimates 750,000, mostly males, are hooked , , MONDAY, May ... and young adults are problem gamblers according to researchers ... , Problem gambling is defined as gambling associated ... more than you intended or stealing money to gamble. ...
... has targeted an,expansion of its human health and performance ... commercial customers based on the success the,company has had ... other,advanced human support services to the space program., ... human performance and engineering services with an emphasis on,risk ...
... All Natural 100% Juice Superfood Smoothie Line has ,Lifeguard(TM) ... ... Sun Shower(TM) is proud to,introduce a new line of all ... Shower(TM) with the added nutritional,benefits of "Lifeguard(TM) Protection," a fortification package ...
... expansion of serialization initiatives, CRANBURY, N.J., ... Packaging Execution Systems (PES) for the pharmaceutical,industry, ... its sales, central engineering and professional services,teams. ... these areas to support,rapid worldwide deployments; specifically, ...
... Pandemic Influenza Initiatives Also,on the Agenda, WASHINGTON, ... Services (HHS) Secretary Mike Leavitt is visiting the ... efforts to improve the,safety of products on which ... The week-long trip to Beijing and Shanghai includes ...
Cached Medicine News:Health News:Queen Rania Launches Situation Analysis of Children in Jordan Highlighting Jordan's Progress in Improving Quality of Life; 6 Ministers Commit to Further Improving Results 2Health News:Queen Rania Launches Situation Analysis of Children in Jordan Highlighting Jordan's Progress in Improving Quality of Life; 6 Ministers Commit to Further Improving Results 3Health News:Queen Rania Launches Situation Analysis of Children in Jordan Highlighting Jordan's Progress in Improving Quality of Life; 6 Ministers Commit to Further Improving Results 4Health News:Problem Gambling Common Among Young Adults 2Health News:Wyle Targets New Customers for Expanded Human Health and Performance Capabilities and Services 2Health News:New Sun Shower(TM) Superfood Smoothies 2Health News:New Sun Shower(TM) Superfood Smoothies 3Health News:Systech Augments Key Departments to Drive Operational Excellence and International Support 2Health News:Systech Augments Key Departments to Drive Operational Excellence and International Support 3Health News:Secretary Leavitt Travels to the People's Republic of China to Check Up on Efforts to Improve Product Safety 2
Designed as an excellent form of primary suspension...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
... orthosis is designed to comfortably restrict ... allowing unobstructed motion of the fingers ... fit the splint may be trimmed ... a heat gun. One cotton stockinet ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: